
Proteostasis Therapeutics Inc (PTI) was a tremendous runner today in the biotech space. The stock traded up to over +390% on extreme volume after the company announced that its study for patients with cystic fibrosis met all of its endpoints, which was fantastic news to investors and traders. Presently I see support at $7.31 but this will likely move higher before the end of today. Here’s a recap of what happened.